NASDAQ$OMDA
Omada Health Inc · Q3 2025 earnings
Q3 2025 earnings ·
Briefing
OMDA reported Q3 2025, revenue of $68M, a net loss of $3.2M, diluted EPS of $-0.06.
For Q3 2025, OMDA reported revenue of $68M, a net loss of $3.2M, diluted EPS of $-0.06. Management discusses operating trends, liquidity, and strategic priorities as disclosed in the quarterly filing.
- Revenue $68M.
- Net loss $3.2M.
- Diluted EPS $-0.06.
Headline financials
Revenue & EPS history
Omada Health Inc · Revenue · Quarterly
$68M
Forward guidance
Management discusses OMDA's outlook, capital deployment, and key risks as disclosed in the earnings materials and periodic report.
Tailwinds
- OMDA cited progress on strategic priorities in the quarterly filing.
- Liquidity and balance sheet support continued operations and investment.
Headwinds
- GAAP profitability remained under pressure in the reported quarter.
- Macro, competitive, and regulatory factors may affect near-term results.
- R&D, credit, or project timing can create quarter-to-quarter volatility.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 4 quarterly earnings reports · overlaid with Q3 2025
-3.9%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+1.7%
Avg return
30 days after
25%
1 / 4 earnings
Positive
+3.3%
Q4 2025
Best reaction
-9.5%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.5% | -2.1% | +9.4% | |
| Q4 2025 | +3.3% | +1.0% | -7.5% | |
| Q3 2025 | -7.1% | -1.9% | -20.0% | |
| Q2 2025 | -2.3% | +3.2% | +24.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro